Vycor Medical, Inc.

Vycor Medical, Inc.

OOTC:VYCO
0.04
USD
0.00
(0.00%)
0.00EPS
2.20MMarket Cap

Total Valuation

USD

As of June 30, 2026, Vycor Medical, Inc. carries a market capitalization of 2.20M, placing it among publicly traded companies globally. Its enterprise value stands at 3.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.20M
Enterprise Value3.00M

Share Statistics

As of June 30, 2026, Vycor Medical, Inc. has 33.37M shares outstanding.

Shares Outstanding33.37M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 1.22, and the price-to-book ratio stands at -0.52.

PS Ratio1.22
PB Ratio-0.52
P/TBV Ratio-0.52
P/FCF Ratio36.82
P/OCF Ratio35.86

Enterprise Valuation

As of June 30, 2026, Vycor Medical, Inc. trades at an EV/EBITDA multiple of 27.20 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.66 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 62.22 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.00M versus a market cap of 2.20M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.66
EV / EBITDA27.20
EV / EBIT62.22

Financial Position

As of June 30, 2026, Vycor Medical, Inc. maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -22.53, indicating conservative leverage, while an interest coverage ratio of 1.06 demonstrates limited ability to service its debt obligations.

Current Ratio0.13
Quick Ratio0.07
Debt / Equity-22.53
Debt / EBITDA8.68
Interest Coverage1.06

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -7.08, reflecting losses generated across the asset base. The company generates approximately 258,210.43 in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.73 indicates how many times Vycor Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-7.08
Revenue Per Employee258,210.43
Employee Count7.00
Inventory Turnover1.73

Stock Price Statistics

USD

As of the close on November 12, 2026, Vycor Medical, Inc.'s stock has declined approximately 74.86% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.10.

52-Week Price Change-74.86%
50-Day Moving Average0.07
200-Day Moving Average0.10

Income Statement

USD

Over the twelve months ended June 30, 2026, Vycor Medical, Inc. generated 1.81M in revenue and converted that into -59,930.00 in net income, yielding earnings per share of 0.00. EBITDA reached 110,312.00, while operating income came in at 48,219.00.

Revenue1.81M
Gross Profit1.51M
Operating Income48,219.00
Pretax Income-56,403.00
Net Income-59,930.00
EBITDA110,312.00
EBIT48,219.00

Balance Sheet

USD

As of June 30, 2026, Vycor Medical, Inc. holds 158,907.00 in cash and equivalents against 957,725.00 in total debt, resulting in a net debt position of 772,118.00. Total book value stands at -4.25M, with working capital of -4.29M providing operational flexibility.

Cash & Cash Equivalents158,907.00
Total Debt957,725.00
Net Debt772,118.00
Equity (Book Value)-4.25M
Book Value Per Share-0.13
Working Capital-4.29M

Cash Flow

USD

Vycor Medical, Inc. produced 61,384.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1,606.00 in capital expenditures, free cash flow totaled 59,778.00 - equivalent to 0.00 per share.

Operating Cash Flow61,384.00
Capital Expenditures-1,606.00
Free Cash Flow59,778.00

Margins

Over the twelve months ended June 30, 2026, Vycor Medical, Inc. posted a gross margin of 83.37, reflecting its pricing power and cost economics. The operating margin of 2.67 and net profit margin of -3.32 provide insight into operational efficiency.

Gross Margin83.37
Operating Margin2.67
Pretax Margin-3.12
Profit Margin-3.32
EBITDA Margin6.10

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 85.19 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 2.72, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.14, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Vycor Medical, Inc. shareholders.

Payout Ratio85.19
Shareholder Yield0.14
FCF Yield2.72

Stock Splits

Vycor Medical, Inc.'s most recent stock split took place on January 15, 2013 with a 150:1 split ratio.

Last Split Date1/15/2013
Split Ratio150:1

Scores

As of June 30, 2026, Vycor Medical, Inc. has an Altman Z-Score of -61.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-61.87